WO2005000281A3 - Derives de pyrazolidinedione - Google Patents
Derives de pyrazolidinedione Download PDFInfo
- Publication number
- WO2005000281A3 WO2005000281A3 PCT/EP2004/006471 EP2004006471W WO2005000281A3 WO 2005000281 A3 WO2005000281 A3 WO 2005000281A3 EP 2004006471 W EP2004006471 W EP 2004006471W WO 2005000281 A3 WO2005000281 A3 WO 2005000281A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compounds
- tautomers
- pharmaceutically acceptable
- geometric isomers
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/542—Alkylated benzaldehydes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/548—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/56—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups
- C07C47/565—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing hydroxy groups all hydroxy groups bound to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/28—Two oxygen or sulfur atoms
- C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
- C07D231/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002529436A CA2529436A1 (fr) | 2003-06-24 | 2004-06-16 | Derives de pyrazolidinedione |
JP2006515947A JP2007506661A (ja) | 2003-06-24 | 2004-06-16 | ピラゾリジンジオン誘導体 |
US10/562,623 US20070037846A1 (en) | 2003-06-24 | 2004-06-16 | Pyrazolidinedione derivatives |
EP04739938A EP1638540A2 (fr) | 2003-06-24 | 2004-06-16 | Dérivés de pyrazolidinedione et leur utilisation comme inhibiteurs d'agrégation plaquettaire |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP03/006616 | 2003-06-24 | ||
PCT/EP2003/006616 WO2005002574A1 (fr) | 2003-06-24 | 2003-06-24 | Derives de pyrazolidinedione et leur utilisation en tant qu'inhibiteurs de l'agregation des plaquettes |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005000281A2 WO2005000281A2 (fr) | 2005-01-06 |
WO2005000281A3 true WO2005000281A3 (fr) | 2005-04-14 |
Family
ID=33547562
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/006616 WO2005002574A1 (fr) | 2003-06-24 | 2003-06-24 | Derives de pyrazolidinedione et leur utilisation en tant qu'inhibiteurs de l'agregation des plaquettes |
PCT/EP2004/006471 WO2005000281A2 (fr) | 2003-06-24 | 2004-06-16 | Derives de pyrazolidinedione |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/006616 WO2005002574A1 (fr) | 2003-06-24 | 2003-06-24 | Derives de pyrazolidinedione et leur utilisation en tant qu'inhibiteurs de l'agregation des plaquettes |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1638540A2 (fr) |
JP (1) | JP2007506661A (fr) |
CN (1) | CN1812782A (fr) |
AU (1) | AU2003249865A1 (fr) |
CA (1) | CA2529436A1 (fr) |
WO (2) | WO2005002574A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005026127A1 (fr) * | 2003-09-11 | 2005-03-24 | Institute Of Medicinal Molecular Design. Inc. | Inhibiteur d'inhibiteur-1 activateur de plasmogene |
WO2007020935A1 (fr) * | 2005-08-17 | 2007-02-22 | Ono Pharmaceutical Co., Ltd. | Agent thérapeutique pour soulager la douleur, comprenant un récepteur p2y12 et/ou un bloqueur de récepteur p2y14 |
TWI391378B (zh) | 2006-03-16 | 2013-04-01 | Astellas Pharma Inc | 喹啉酮衍生物或其製藥學上可被容許之鹽 |
EP2238128B1 (fr) | 2007-12-26 | 2012-08-22 | Sanofi | Pyrazole-carboxamides hétérocycliques utilisés en tant qu'antagonistes du récepteur p2y12 |
EP2238127B1 (fr) | 2007-12-26 | 2012-08-15 | Sanofi | Dérivés de pyrazole-carboxamide utiles en tant qu'antagonistes de p2y12 |
JP6016788B2 (ja) * | 2011-05-16 | 2016-10-26 | 国立大学法人九州大学 | DOCK−Aサブファミリー分子によるRac活性化を制御する低分子化合物及びその用途 |
US10822357B2 (en) | 2015-08-28 | 2020-11-03 | Sekisui Medical Co., Ltd. | Benzyl compound |
WO2017131149A1 (fr) * | 2016-01-29 | 2017-08-03 | 小野薬品工業株式会社 | Dérivé de tétrahydronaphtalène |
MA49887A (fr) * | 2017-03-15 | 2020-06-24 | Idorsia Pharmaceuticals Ltd | Administration sous-cutanée d'un antagoniste du récepteur p2y12 |
EP3661912B9 (fr) | 2017-07-31 | 2024-02-28 | Horitzonts Tecnologics Hungary Korlátolt Felelosségu Társaság | Composés destinés au traitement d'infections |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2012634A1 (fr) * | 1990-03-20 | 1991-09-20 | Hassan Salari | Tyrphostines pour le traitement des allergies et des affections inflammatoires et cardiovasculaires |
WO2001009121A2 (fr) * | 1999-07-30 | 2001-02-08 | Basf Aktiengesellschaft | 2-pyrazolin-5-ones |
WO2002102359A2 (fr) * | 2001-06-18 | 2002-12-27 | Applied Research Systems Ars Holding N.V. | Derives d'alkylidene pyrazolidinedione |
WO2003074550A2 (fr) * | 2002-03-01 | 2003-09-12 | Pintex Pharmaceuticals, Inc. | Composes de modulation de pin1 et procedes d'utilisation correspondant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1404682B1 (fr) * | 2001-06-29 | 2005-09-14 | Novo Nordisk A/S | Procede permettant d'inhiber ptp1b et / ou ptp de lymphocyteet et / ou d'autres ptpases a reste asp en position 48 |
-
2003
- 2003-06-24 AU AU2003249865A patent/AU2003249865A1/en not_active Abandoned
- 2003-06-24 WO PCT/EP2003/006616 patent/WO2005002574A1/fr active Application Filing
-
2004
- 2004-06-16 CA CA002529436A patent/CA2529436A1/fr not_active Abandoned
- 2004-06-16 CN CNA2004800177171A patent/CN1812782A/zh active Pending
- 2004-06-16 EP EP04739938A patent/EP1638540A2/fr not_active Withdrawn
- 2004-06-16 JP JP2006515947A patent/JP2007506661A/ja active Pending
- 2004-06-16 WO PCT/EP2004/006471 patent/WO2005000281A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2012634A1 (fr) * | 1990-03-20 | 1991-09-20 | Hassan Salari | Tyrphostines pour le traitement des allergies et des affections inflammatoires et cardiovasculaires |
WO2001009121A2 (fr) * | 1999-07-30 | 2001-02-08 | Basf Aktiengesellschaft | 2-pyrazolin-5-ones |
WO2002102359A2 (fr) * | 2001-06-18 | 2002-12-27 | Applied Research Systems Ars Holding N.V. | Derives d'alkylidene pyrazolidinedione |
WO2003074550A2 (fr) * | 2002-03-01 | 2003-09-12 | Pintex Pharmaceuticals, Inc. | Composes de modulation de pin1 et procedes d'utilisation correspondant |
Also Published As
Publication number | Publication date |
---|---|
AU2003249865A1 (en) | 2005-01-21 |
JP2007506661A (ja) | 2007-03-22 |
CN1812782A (zh) | 2006-08-02 |
CA2529436A1 (fr) | 2005-01-16 |
WO2005000281A2 (fr) | 2005-01-06 |
EP1638540A2 (fr) | 2006-03-29 |
WO2005002574A1 (fr) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ588830A (en) | Inhibitors of protein kinases | |
ZA200500887B (en) | Use of and some novel imidazopyridines. | |
ZA200501098B (en) | Novel use of benzothiazole derivatives | |
MY140638A (en) | New heterocyclic compounds, which are active as inhibitors of beta-lactamases | |
MX347706B (es) | Derivados de triazol y su uso para trastornos neurologicos. | |
WO2008132142A3 (fr) | Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central | |
WO2003064404A1 (fr) | Hydrazides d'acide 2-furancarboxylique et compositions pharmaceutiques les contenant | |
MX2010005299A (es) | Derivados de bis-(sulfonilamino) en terapia 066. | |
NZ589315A (en) | 2,6-diamino-pyrimidin-5-yl-carboxamides as Spleen tryosine kinase (syk) or Janus kinase (JAK) inhibitors | |
WO2006024486A3 (fr) | Derives amide de 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, leur fabrication et leur utilisation en tant qu'agents pharmaceutiques | |
PL1678166T3 (pl) | Inhibitory kinaz białkowych | |
WO2007040438A3 (fr) | Derives d'imidazo(4,5-b) pyridine utilises comme inhibiteurs de la glycogene synthase kinase 3 pour le traitement de la demence et de troubles neurodegeneratifs | |
ECSP088913A (es) | Derivados de pirimidina tieno [3,2-d] utiles como inhibidores de fi3q | |
TW200745136A (en) | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
GEP20074124B (en) | Azaindole kinase inhibitors | |
UA84878C2 (ru) | Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения | |
PT1797099E (pt) | Compostos de piperidinilamino-tieno[2,3-d]pirimidina | |
IL158975A0 (en) | 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors | |
NO20075059L (no) | Nye forbindelser II 2-pyridinderivater som inhibitorer av neutrofil elastase | |
WO2007122634A3 (fr) | Inhibiteurs de kinase | |
BG108868A (en) | Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds | |
MX2009010731A (es) | Derivados de acido 1-(1-bencilpiperidin-4-il)benzimidazol-5-carbox ilico para el tratamiento de diabetes mellitus. | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav | |
NO20091254L (no) | Terapeutiske sammensetninger | |
WO2005000281A3 (fr) | Derives de pyrazolidinedione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2529436 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006515947 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004739938 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20048177171 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2004739938 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007037846 Country of ref document: US Ref document number: 10562623 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10562623 Country of ref document: US |